{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:04:07Z","timestamp":1762272247438,"version":"build-2065373602"},"reference-count":19,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BLCTT"],"DOI":"10.2147\/blctt.s556608","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:50:17Z","timestamp":1762271417000},"page":"193-202","source":"Crossref","is-referenced-by-count":0,"title":["Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Yutian","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-4261","authenticated-orcid":true,"given":"Xiaoli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sixuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-4027","authenticated-orcid":true,"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/S2352-3026(22)00319-2","volume":"10","author":"Jabbour","year":"2023","journal-title":"Lancet Haematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1200\/JCO.23.01075","volume":"42","author":"Fo\u00e0","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cncr.34666","volume":"129","author":"Logan","year":"2023","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/cncr.34667","volume":"129","author":"Queudeville","year":"2023","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2344998","DOI":"10.1080\/16078454.2024.2344998","volume":"29","author":"Hao","year":"2024","journal-title":"Hematology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/ejh.14015","volume":"111","author":"Canaani","year":"2023","journal-title":"Eur J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/bloodadvances.2024014405","volume":"9","author":"Luskin","year":"2025","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00277-023-05127-3","volume":"102","author":"Chang","year":"2023","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/hon.2794","volume":"38","author":"Murakami","year":"2020","journal-title":"Hematol Oncol"},{"key":"ref10","unstructured":"NCCN clinical practice guidelines in oncology-acute lymphoblastic leukemia (Version 3.2024). Available from: www.nccn.org. Accessed May 1, 2025."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/cncr.20668","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa1609783","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1200\/JCO.21.01766","volume":"40","author":"Advani","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/01.HS9.0000844352.62588.a4","volume":"6","author":"Rijneveld","year":"2022","journal-title":"HemaSphere"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2141.2012.09095.x","volume":"157","author":"Sive","year":"2012","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-024-01597-8","volume":"17","author":"Lu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41409-020-01134-4","volume":"56","author":"Sheth","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood and Lymphatic Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/108573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/108573","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:50:22Z","timestamp":1762271422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/venetoclax-plus-blinatumoma-as-first-line-therapy-for-newly-diagnosed--peer-reviewed-fulltext-article-BLCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2147\/blctt.s556608","relation":{},"ISSN":["1179-9889"],"issn-type":[{"value":"1179-9889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}